Patent · US Active

Lactobacillus supplement for alleviating type 1 diabetes

US9474773B2 · kind B2 · utility

2Cited by

7References

13Claims

0Family size

Assignee

University of Florida Research Foundation, INC. · US

Inventors

Josef Neu · Gainesville, US
Graciela Liliana Lorca · Gainesville, US
Eric W. Triplett · Madison, US
Mark A. Atkinson · Gainesville, US
Desmond A. Schatz · Gainesville, US

Key dates

Filing date	Feb 18, 2010
Grant date	Oct 25, 2016
Priority date	—
Expiry date	Feb 26, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2400/173
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated Lactobacillus strains are useful in preventing or delaying the development of Type 1 Diabetes (T1D). A probiotic composition comprising the Lactobacillus strains and use of the composition in T1D prevention are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.